Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Pozycja w akcjach #41
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Cena akcji
$459.10
Ostatnia synchronizacja: 2026-09-11
Kapitalizacja rynkowa
$359.91B
Zmiana (1 dzień)
0.11%
Zmiana (1 rok)
30.72%
Kraj
CH
Handel Roche Holding AG (RO)

Kategoria

Zyski dla Roche Holding AG (RO)
Zyski w Dec 2025 TTM: $21.39B
Według najnowszych raportów finansowych Roche Holding AG, obecny zysk firmy wynosi $21.39B. W roku 2024 firma osiągnęła zysk w wysokości $13.06B, spadek w porównaniu do zysku z roku 2023, który wynosił $16.74B. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Roche Holding AG od 2000 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $21.39B 0.00%
2025 $21.39B 63.83%
2024 $13.06B -22.02%
2023 $16.74B -5.44%
2022 $17.70B -7.24%
2021 $19.09B -4.57%
2020 $20.00B 16.46%
2019 $17.17B 19.41%
2018 $14.38B 14.44%
2017 $12.57B -1.66%
2016 $12.78B 6.57%
2015 $11.99B -4.81%
2014 $12.60B -23.40%
2013 $16.45B 22.16%
2012 $13.46B 6.42%
2011 $12.65B 5.47%
2010 $12.00B 21.15%
2009 $9.90B -25.31%
2008 $13.26B -2.09%
2007 $13.54B 31.16%
2006 $10.32B 51.54%
2005 $6.81B -18.34%
2004 $8.34B 111.44%
2003 $3.95B -270.88%
2002 $-2.31B -180.67%
2001 $2.86B -50.86%
2000 $5.82B 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$33.59B 57.07%
US
$25.20B 17.80%
US
$8.70B -59.33%
US
$5.95B -72.19%
US
$16.38B -23.42%
CH